Employer profile
Celesta Medical Services
1 certified H-1B filings across 1 fiscal year.
FY2023 filings
1
FY2023 median
$153k
Top role
Chief Scientist
1 filings
Top state
FL
1 filings
Celesta Medical Services has filed 1 certified H-1B Labor Condition Applications over FY2023. In FY2023, its median certified base salary was $153k ($153k–$153k interquartile range). The most-filed role is Chief Scientist (1 filings).
Year-over-year
How Celesta Medical Services hired across H-1B fiscal years. YoY column compares to the prior FY.
| FY | Filings | Median $ | YoY % |
|---|---|---|---|
| FY2023 | 1 | $153k | — |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Chief Scientist | 1 | $153k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| FL | 1 | $153k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl IV
1100%
Frequently asked questions
- Does Celesta Medical Services sponsor H-1B visas?
- Yes. Celesta Medical Services has filed 1 certified H-1B Labor Condition Applications (LCAs) over FY2023. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at Celesta Medical Services?
- In FY2023, the median certified H-1B base salary at Celesta Medical Services was $153k, with a 25th–75th percentile range of $153k–$153k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does Celesta Medical Services hire H-1B workers for?
- Celesta Medical Services's most-filed H-1B role is Chief Scientist (1 filings). Its top worksite state is FL.
- How many H-1B filings did Celesta Medical Services submit in FY2023?
- Celesta Medical Services had 1 certified H-1B LCA filings in FY2023.